PETMED EXPRESS INC (PETS) Stock Fundamental Analysis
NASDAQ:PETS - Nasdaq - US7163821066 - Common Stock - Currency: USD
Taking everything into account, PETS scores 4 out of 10 in our fundamental rating. PETS was compared to 121 industry peers in the Specialty Retail industry. While PETS has a great health rating, there are worries on its profitability. PETS is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
PETS had positive earnings in the past year.
In the past year PETS had a positive cash flow from operations.
Of the past 5 years PETS 4 years were profitable.
Each year in the past 5 years PETS had a positive operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of 0.25%, PETS is in line with its industry, outperforming 47.93% of the companies in the same industry.
PETS's Return On Equity of 0.37% is in line compared to the rest of the industry. PETS outperforms 52.89% of its industry peers.
PETS has a Return On Invested Capital (1.24%) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.25% | ||
| ROE | 0.37% | ||
| ROIC | 1.24% |
ROA(3y)2.57%
ROA(5y)8.14%
ROE(3y)2.43%
ROE(5y)9.77%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
PETS has a Profit Margin (0.14%) which is in line with its industry peers.
With a Operating Margin value of 0.62%, PETS is not doing good in the industry: 61.98% of the companies in the same industry are doing better.
Looking at the Gross Margin, with a value of 27.68%, PETS is doing worse than 71.07% of the companies in the same industry.
PETS's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 0.62% | ||
| PM (TTM) | 0.14% | ||
| GM | 27.68% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.27%
GM growth 5Y-3.61%
2. Health
2.1 Basic Checks
PETS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for PETS has been increased compared to 1 year ago.
The number of shares outstanding for PETS has been increased compared to 5 years ago.
There is no outstanding debt for PETS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
An Altman-Z score of 3.56 indicates that PETS is not in any danger for bankruptcy at the moment.
The Altman-Z score of PETS (3.56) is better than 81.82% of its industry peers.
There is no outstanding debt for PETS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 3.56 |
ROIC/WACC0.14
WACC9.18%
2.3 Liquidity
PETS has a Current Ratio of 1.43. This is a normal value and indicates that PETS is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of PETS (1.43) is comparable to the rest of the industry.
PETS has a Quick Ratio of 1.18. This is a normal value and indicates that PETS is financially healthy and should not expect problems in meeting its short term obligations.
With an excellent Quick ratio value of 1.18, PETS belongs to the best of the industry, outperforming 80.99% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.43 | ||
| Quick Ratio | 1.18 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 102.56% over the past year.
PETS shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -10.82%.
Measured over the past years, PETS shows a decrease in Revenue. The Revenue has been decreasing by -0.17% on average per year.
EPS 1Y (TTM)102.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%70%
Revenue 1Y (TTM)-10.82%
Revenue growth 3Y-3.13%
Revenue growth 5Y-0.17%
Sales Q2Q%-18.88%
3.2 Future
Based on estimates for the next years, PETS will show a very strong growth in Earnings Per Share. The EPS will grow by 29.72% on average per year.
PETS is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -7.74% yearly.
EPS Next Y153.62%
EPS Next 2Y34.31%
EPS Next 3Y29.72%
EPS Next 5YN/A
Revenue Next Year-17.16%
Revenue Next 2Y-9.97%
Revenue Next 3Y-7.74%
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
PETS is valuated quite expensively with a Price/Earnings ratio of 350.00.
Based on the Price/Earnings ratio, PETS is valued a bit more expensive than 61.16% of the companies in the same industry.
PETS is valuated expensively when we compare the Price/Earnings ratio to 28.79, which is the current average of the S&P500 Index.
The Forward Price/Earnings Ratio is negative for PETS. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 350 | ||
| Fwd PE | N/A |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, PETS is valued cheaply inside the industry as 94.21% of the companies are valued more expensively.
The rest of the industry has a similar Price/Free Cash Flow ratio as PETS.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 84.57 | ||
| EV/EBITDA | 2.7 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as PETS's earnings are expected to grow with 29.72% in the coming years.
PEG (NY)2.28
PEG (5Y)N/A
EPS Next 2Y34.31%
EPS Next 3Y29.72%
5. Dividend
5.1 Amount
PETS does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
3.5
-0.02 (-0.57%)
Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)
Earnings (Next)
Inst Owners44.55%
Inst Owner Change0.06%
Ins Owners8.21%
Ins Owner Change13.34%
Market Cap72.31M
Analysts42.86
Price Target3.67 (4.86%)
Short Float %12.1%
Short Ratio8.04
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0.59
Dividend Growth(5Y)-11.13%
DP54.34%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-96.08%
Min EPS beat(2)-488.23%
Max EPS beat(2)296.08%
EPS beat(4)2
Avg EPS beat(4)-36.55%
Min EPS beat(4)-488.23%
Max EPS beat(4)296.08%
EPS beat(8)3
Avg EPS beat(8)-169.93%
EPS beat(12)4
Avg EPS beat(12)-128.55%
EPS beat(16)4
Avg EPS beat(16)-101.84%
Revenue beat(2)0
Avg Revenue beat(2)-12.18%
Min Revenue beat(2)-12.84%
Max Revenue beat(2)-11.51%
Revenue beat(4)1
Avg Revenue beat(4)-8.81%
Min Revenue beat(4)-12.84%
Max Revenue beat(4)0.31%
Revenue beat(8)1
Avg Revenue beat(8)-6.94%
Revenue beat(12)1
Avg Revenue beat(12)-6.81%
Revenue beat(16)1
Avg Revenue beat(16)-6.96%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-80%
EPS NY rev (1m)0%
EPS NY rev (3m)20.59%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-12.9%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-10.07%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 350 | ||
| Fwd PE | N/A | ||
| P/S | 0.29 | ||
| P/FCF | 84.57 | ||
| P/OCF | 14.97 | ||
| P/B | 0.75 | ||
| P/tB | 1.33 | ||
| EV/EBITDA | 2.7 |
EPS(TTM)0.01
EY0.29%
EPS(NY)-0.08
Fwd EYN/A
FCF(TTM)0.04
FCFY1.18%
OCF(TTM)0.23
OCFY6.68%
SpS11.96
BVpS4.66
TBVpS2.64
PEG (NY)2.28
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.25% | ||
| ROE | 0.37% | ||
| ROCE | 1.57% | ||
| ROIC | 1.24% | ||
| ROICexc | 2.57% | ||
| ROICexgc | 23.86% | ||
| OM | 0.62% | ||
| PM (TTM) | 0.14% | ||
| GM | 27.68% | ||
| FCFM | 0.35% |
ROA(3y)2.57%
ROA(5y)8.14%
ROE(3y)2.43%
ROE(5y)9.77%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.27%
GM growth 5Y-3.61%
F-Score7
Asset Turnover1.71
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 57.96% | ||
| Cap/Sales | 1.61% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 57.63% | ||
| Profit Quality | 239.5% | ||
| Current Ratio | 1.43 | ||
| Quick Ratio | 1.18 | ||
| Altman-Z | 3.56 |
F-Score7
WACC9.18%
ROIC/WACC0.14
Cap/Depr(3y)91.99%
Cap/Depr(5y)95.64%
Cap/Sales(3y)1.43%
Cap/Sales(5y)1.18%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)102.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%70%
EPS Next Y153.62%
EPS Next 2Y34.31%
EPS Next 3Y29.72%
EPS Next 5YN/A
Revenue 1Y (TTM)-10.82%
Revenue growth 3Y-3.13%
Revenue growth 5Y-0.17%
Sales Q2Q%-18.88%
Revenue Next Year-17.16%
Revenue Next 2Y-9.97%
Revenue Next 3Y-7.74%
Revenue Next 5YN/A
EBIT growth 1Y111.94%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year161.4%
EBIT Next 3Y51.6%
EBIT Next 5YN/A
FCF growth 1Y-96.28%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-81.97%
OCF growth 3Y-52.42%
OCF growth 5Y-37.46%